hormone

(redirected from luteinizing hormone-releasing hormone)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to luteinizing hormone-releasing hormone: luteinizing hormone-releasing hormone agonist
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for hormone

References in periodicals archive ?
Incomplete testosterone suppression with luteinizing hormone-releasing hormone agonists: Does it happen and does it matter?
Effect of luteinizing hormone-releasing hormone analogs on the rat ovarian follicle development.
Sudden death due to disease flare with luteinizing hormone-releasing hormone agonist therapy for carcinoma of the prostate.
N-methyl D,L-aspartate induces the release of luteinizing hormone-releasing hormone in the prepubertal and pubertal rhesus monkey as measured by in vivo push-pull perfusion in the stalk-median eminence.
Ozarelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, was in late stage trials for the treatment of benign prostatic hypertrophy.
Long-acting luteinizing hormone-releasing hormone (LHRH) agonists, such as goserelin, have been used for locally advanced and metastatic prostate cancer for many years and are the main forms of androgen deprivation therapy (ADT).
Treatment with a luteinizing hormone-releasing hormone agonist or with combined androgen blockade would add 7.
2] Others proposed induced amenorrhea by oral contraceptive pills or by luteinizing hormone-releasing hormone analog because epithelial and stromal cells that contain sex hormone receptors (as in the endometrium) had been observed within the fistula.
Cetrorelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, had been the object of a Phase III programme in BPH, a non-cancerous enlargement of the prostate which, as reported by the company last week, did not meet its primary endpoint.
As a class, the aromatase inhibitor brands achieved higher sales than the luteinizing hormone-releasing hormone analog, anti-androgen or anti-estrogen brands in 2007, achieving $2.
Time to normalization of serum testosterone after 3-month luteinizing hormone-releasing hormone agonist administered in the neoadjuvant setting: implications for dosing schedule and neoadjuvant study consideration.
In a personalised health care approach, the study selected patients with tumours expressing luteinizing hormone-releasing hormone (LHRH) receptors, the key element in the targeting mechanism of AEZS-108.
TSX:PLB), a leading Canadian specialty pharmaceutical company, today announced that Health Canada has approved VANTAS(R), a unique, once-yearly luteinizing hormone-releasing hormone (LHRH) implant indicated for the palliative treatment of advanced prostate cancer, the most prevalent form of cancer afflicting Canadian men.
Pai and colleagues report a small randomized controlled trial (RCT) examining whether men who receive 6 months of neoadjuvant androgen deprivation therapy for cytoreduction recover faster whether they receive a monthly luteinizing hormone-releasing hormone agonist (LHRHa) or an injection every 3 months.
Full browser ?